The Valley Desk

NCT04551131 · Interventional trial

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Hemophagocytic Lymphohistiocytosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov